Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06512402
NA

Epinephrine Vs Norepinephrine Infusion During Caesarean Delivery

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

Epinephrine is a well-known vasoactive agent in medical practice. However, its use is obstetric population is still scanty. Few studies evaluated the use of epinephrine during Cesarean delivery and a recent randomized controlled dose-finding trial reached an acceptable incidence of hypotension (13%) with the use of 0.03 mcg/kg/min as prophylaxis. Being a newly introduced vasoactive agent in obstetric practice, it is essential to be adequately compared with other vasopressors using the optimum dosage and appropriate outcomes. There are no data, till date, comparing epinephrine versus norepinephrine infusion during Cesarean delivery using a composite outcome of hypotension, hypertension, and bradycardia. The aim of this study is to compare epinephrine versus norepinephrine infusion for prophylaxis against post-spinal hypotension during Caesarean delivery

Official title: Epinephrine Versus Norepinephrine Infusion for Prevention of Maternal Hypotension During Caesarean Delivery: a Randomized Clinical Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

212

Start Date

2024-08

Completion Date

2024-12

Last Updated

2024-07-22

Healthy Volunteers

No

Interventions

DRUG

Norepinephrine

patients will receive norepinephrine infusion at rate of 0.05 mcg/Kg/min

DRUG

Epinephrine

patients will receive epinephrine infusion dose of 0.03 mcg/Kg/min

Locations (1)

Cairo University

Cairo, Egypt